L'intérêt à découvert pour Cognex donne aux investisseurs une idée du degré auquel les investisseurs parient sur la baisse de l'action de Cognex. Les données sur l'intérêt à découvert sont mises à jour toutes les deux semaines.

Cognex (NASDAQ:CGNX) Stock, Rapport sur les intérêts à découvert

COGNEX CORP

Cognex

Cognex Corp provides machine vision products that help automate manufacturing processes. The firm's products include vision software, vision systems, vision sensors, and ID products. Vision software combines vision tools with a customer's cameras and peripheral equipment and can help with several vision tasks, including part location, identification, measurement, and robotic guidance. Vision systems combine a camera, processor, and vision software into a single package. Vision sensors deliver simple, low-cost solutions for common vision applications, such as checking the size of parts. ID products read codes that have been applied to items during the manufacturing process. Cognex generates the maximum proportion of its sales in the United States and Europe.

Cognex Corp

On CNBC's &#8220;<a href="https://www.cnbc.com/video/2025/07/21/final-trades-morgan-stanley-netflix-cognex-and-eqt-corp.html">Halftime Report Final Trades</a>,&#8221; Sarat Sethi, Managing Partner at DCLA, said Morgan Stanley (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MS#NYSE">MS</a>) reported <a href="https://www.benzinga.com/quote/MS/earnings">great earnings.</a>
Morgan Stanley reported second-quarter 2025 earnings of $2.13 on July 16, up from $1.82 a year ago and exceeding the consensus estimate of $2.02. Net earnings increased to $3.54 billion from $3.08 billion. The U.S. bank reported revenue of $16.79 billion, up 12% year-over-year, beating the consensus estimate of $16.11 billion.
Stephen Weiss, Chief Investment Officer and Managing Partner of Short Hills Capital Partners, said Netflix, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NFLX#NASDAQ">NFLX</a>) was unfairly penalized for the quarter. He still thinks it's a good opportunity.
Netflix, on July 17. reported second-quarter revenue of $11.08 billion, up 16% year-over-year. The revenue total beat a Street consensus estimate of $11.04 billion, according to data from Benzinga Pro. The company reported second-quarter earnings per share of $7.19, beating a Street consensus estimate of $7.06.
Don't forget to check out our <a href="https://www.benzinga.com/premarket/">premarket coverage here</a>
Amy Raskin, CIO at Chevy Chase Trust, named Cognex Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CGNX#NASDAQ">CGNX</a>) as her final trade.
Lending support to her choice, Citigroup analyst Piyush Avasthy, on July 14, raised the price target on the stock from $30 to $37.
Joseph M. Terranova, Senior Managing Director for Virtus Investment Partners, picked EQT Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EQT#NYSE">EQT</a>), which saw a sharp decline on Monday.
EQT will issue its second quarter financial and operating results news release after the closing bell on Tuesday, July 22.
Price Action:
<ul class="wp-block-list">
<li>Morgan Stanley shares fell 0.3% to close at $140.47 on Monday.</li>
<li>Netflix shares dipped 5.1% to settle at $1,209.24 during the session.</li>
<li>Cognex shares fell 1% to close at $33.73 during the session.</li>
<li>EQT shares tumbled 9.6% to settle at $53.54 on Monday.</li>
</ul>
Check This Out: 
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/trading-ideas/short-ideas/25/07/46517205/top-2-financial-stocks-that-may-plunge-this-month">Top 2 Financial Stocks That May Plunge This Month</a></li>
</ul>
Image: Shutterstock

Long Ideas

News

Markets

Media

Trading Ideas

CGNX

NFLX

Morgan Stanley, Netflix, Cognex And An Energy Stock: CNBC's 'Final Trades'

Analyst Ratings

CNBC Halftime Report Final Trades: Morgan Stanley, Netflix, Cognex, EQT Corporation

Rumors

Watching Cognex; Shares See Volume To The Upside, Stock Reportedly Picked By Popular Traders Newsletter

Citigroup analyst Piyush Avasthy maintains Cognex (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CGNX#NASDAQ">CGNX</a>) with a Neutral and raises the price target from $30 to $37.

Price Target

Citigroup Maintains Neutral on Cognex, Raises Price Target to $37

In the current market session, Cognex Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CGNX#NASDAQ">CGNX</a>) share price is at $32.29, after a 1.49% drop. Over the past month, the stock increased by 7.54%, but over the past year, it actually decreased by 31.22%. With good short-term performance like this, and questionable long-term performance, long-term shareholders might want to start looking into the company's price-to-earnings ratio.

<img src="https://www.benzinga.com/files/images/story/2025/1751580019_0.png" alt="Past Year Chart" />

<h3>Cognex P/E Compared to Competitors</h3>
The P/E ratio is used by long-term shareholders to assess the company's market performance against aggregate market data, historical earnings, and the industry at large. A lower P/E could indicate that shareholders do not expect the stock to perform better in the future or it could mean that the company is undervalued. 
Compared to the aggregate P/E ratio of 41.59 in the Electronic Equipment, Instruments &amp; Components industry, Cognex Inc. has a higher P/E ratio of 47.52. Shareholders might be inclined to think that Cognex Inc. might perform better than its industry group. It's also possible that the stock is overvalued. 

<img src="https://www.benzinga.com/files/images/story/2025/1751580019_1.png" alt="Guage" />

In summary, while the price-to-earnings ratio is a valuable tool for investors to evaluate a company's market performance, it should be used with caution. A low P/E ratio can be an indication of undervaluation, but it can also suggest weak growth prospects or financial instability. Moreover, the P/E ratio is just one of many metrics that investors should consider when making investment decisions, and it should be evaluated alongside other financial ratios, industry trends, and qualitative factors. By taking a comprehensive approach to analyzing a company's financial health, investors can make well-informed decisions that are more likely to lead to successful outcomes.

Intraday Update

P/E Ratio Insights for Cognex

The global market for humanoid robots is set to soar, with a UBS report predicting a significant increase in their numbers by 2050. This forecast is expected to have a substantial impact on various industries.
What Happened: A recent report by UBS, led by analysts in China, suggests that the number of humanoid robots in operation will reach 2 million by 2035 and a staggering 300 million by 2050. This surge is anticipated to address labor shortages and cater to aging populations, <a href="https://www.marketwatch.com/story/300-million-humanoid-robots-are-coming-and-here-are-the-companies-that-will-benefit-04c36ae8?mod=home_ln">MarketWatch</a> reported.
The report projects the market could reach $30 billion to $50 billion by 2035, and soar to between $1.4 trillion and $1.7 trillion by 2050, encompassing expenditures on components, manufacturing, software, data, and services. 
By 2050, 86 million humanoid robots could add $400 billion to global automation revenue and $7 billion to rare-earth revenue, with costs expected to drop over 70% due to scale and supply chain gains.
UBS analyst Phyllis Wang emphasized the potential of humanoid robots for everyday use but noted that their widespread adoption could take over five years.
Several industries are expected to benefit from this projected surge in humanoid robots, including global automation, auto parts, semiconductor, battery companies, and rare-earth refiners. UBS has identified companies such as NVIDIA (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NVDA#NASDAQ">NVDA</a>), Honeywell (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HON#NASDAQ">HON</a>), TSMC (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TSM#NASDAQ">TSM</a>), ]Cognex (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CGNX#NASDAQ">CGNX</a>), Amphenol NYSE: (APH) and several Chinese companies as potential beneficiaries.
Even Tesla (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TSLA#NASDAQ">TSLA</a>), which is not rated as a buy by UBS, is expected to benefit from this.
SEE ALSO: <a href="https://benzinga.com/news/politics/25/06/45988984/anthony-scaramucci-quotes-harry-truman-to-take-a-sly-dig-at-trumps-recent-ventures-show-me-a-man-that-gets-rich-by-being-a-politician" target="_blank" rel="noreferrer noopener">Anthony Scaramucci Quotes Harry Truman To Take A Sly Dig At Trump&#8217;s Recent Ventures? — &#8216;Show Me A Man That Gets Rich By Being A Politician…&#8217; &#8211; Benzinga</a>
Why It Matters: This prediction aligns with recent developments in the robotics industry. In May 2025, <a href="https://www.benzinga.com/tech/25/05/45495742/nvidia-unveils-ai-tools-for-humanoid-robots-launches-next-tech-era">NVIDIA unveiled AI tools</a> to accelerate humanoid robot development, which were adopted by several robotics developers, while, <a href="https://www.benzinga.com/news/topics/25/05/45710538/elon-musk-says-humanoid-robots-will-start-impacting-countries-gdps-in-4-to-5-years-robot-cars-even-sooner-in-just-1-to-2-years">Elon Musk predicted</a> that humanoid robots would start impacting countries&#8217; GDPs in 4 to 5 years.
Furthermore, <a href="https://www.benzinga.com/news/25/05/45185633/ups-explores-humanoid-robots-as-figure-ai-secures-675m-from-jeff-bezos-openai-and-intel-targeting-9b-revenue-by-2029">UPS explored humanoid robots</a> for its logistics infrastructure as Figure AI secured $675M from tech giants, targeting $9B revenue by 2029.
Meanwhile, Apple Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AAPL#NASDAQ">AAPL</a>) and Meta Platforms Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/META#NASDAQ">META</a>), are also reportedly preparing to go head-to-head in the race to develop artificial intelligence (AI)-powered<a href="https://www.benzinga.com/tech/25/02/43759759/apple-and-meta-in-race-to-develop-ai-powered-humanoid-robots"> humanoid robots</a>.
<ul class="wp-block-list">
<li>READ MORE: <a href="https://benzinga.com/crypto/25/06/45990237/dogecoin-price-tumbles-15-in-a-week-but-this-analyst-says-1-25-target-could-still-be-in-play" target="_blank" rel="noreferrer noopener">Dogecoin Price Tumbles 15% In A Week, But This Analyst Says $1.25 Target Could Still Be In Play &#8211; Benzinga</a></li>
</ul>
Image via Shutterstock
Disclaimer:&nbsp;This content was partially produced with the help of AI tools and was reviewed and published by Benzinga editors.

AAPL

NVDA

TSLA

Nvidia, Tesla, Honeywell Could Ride $1.7 Trillion Robot Wave As UBS Sees 300 Million Humanoids By 2050

DA Davidson analyst Matthew Summerville maintains Cognex (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CGNX#NASDAQ">CGNX</a>) with a Neutral and maintains $32 price target.

DA Davidson Maintains Neutral on Cognex, Maintains $32 Price Target

Baird analyst Richard Eastman maintains Cognex (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CGNX#NASDAQ">CGNX</a>) with a Neutral and raises the price target from $30 to $32.

Baird Maintains Neutral on Cognex, Raises Price Target to $32

Goldman Sachs analyst Joe Ritchie maintains Cognex (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CGNX#NASDAQ">CGNX</a>) with a Sell and raises the price target from $29 to $32.

Goldman Sachs Maintains Sell on Cognex, Raises Price Target to $32

Across the recent three months, 7 analysts have shared their insights on Cognex (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CGNX#NASDAQ">CGNX</a>), expressing a variety of opinions spanning from bullish to bearish.
The table below summarizes their recent ratings, showcasing the evolving sentiments within the past 30 days and comparing them to the preceding months.
<table>
<thead>
<tr>
<th></th>
<th align="right">Bullish</th>
<th align="right">Somewhat Bullish</th>
<th align="right">Indifferent</th>
<th align="right">Somewhat Bearish</th>
<th align="right">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td align="right">3</td>
<td align="right">0</td>
<td align="right">3</td>
<td align="right">0</td>
<td align="right">1</td>
</tr>
<tr>
<td>Last 30D</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td align="right">2</td>
<td align="right">0</td>
<td align="right">2</td>
<td align="right">0</td>
<td align="right">1</td>
</tr>
<tr>
<td>3M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
In the assessment of 12-month price targets, analysts unveil insights for Cognex, presenting an average target of $34.0, a high estimate of $53.00, and a low estimate of $26.00. Experiencing a 12.51% decline, the current average is now lower than the previous average price target of $38.86. 
<img src="https://www.benzinga.com/files/images/story/2025/1749643257_0.png" alt="price target chart" />
<h2>Investigating Analyst Ratings: An Elaborate Study</h2>
An in-depth analysis of recent analyst actions unveils how financial experts perceive Cognex. The following summary outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>James Ricchiuti</td>
<td>Needham</td>
<td>Raises</td>
<td>Buy</td>
<td>$36.00</td>
<td>$33.00</td>
</tr>
<tr>
<td>Joe Ritchie</td>
<td>Goldman Sachs</td>
<td>Lowers</td>
<td>Sell</td>
<td>$29.00</td>
<td>$33.00</td>
</tr>
<tr>
<td>Matthew Summerville</td>
<td>DA Davidson</td>
<td>Lowers</td>
<td>Neutral</td>
<td>$32.00</td>
<td>$35.00</td>
</tr>
<tr>
<td>Damian Karas</td>
<td>UBS</td>
<td>Lowers</td>
<td>Buy</td>
<td>$53.00</td>
<td>$56.00</td>
</tr>
<tr>
<td>James Ricchiuti</td>
<td>Needham</td>
<td>Lowers</td>
<td>Buy</td>
<td>$33.00</td>
<td>$41.00</td>
</tr>
<tr>
<td>Piyush Avasthy</td>
<td>Citigroup</td>
<td>Lowers</td>
<td>Neutral</td>
<td>$26.00</td>
<td>$37.00</td>
</tr>
<tr>
<td>Jamie Cook</td>
<td>Truist Securities</td>
<td>Lowers</td>
<td>Hold</td>
<td>$29.00</td>
<td>$37.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: Analysts respond to changes in market conditions and company performance, frequently updating their recommendations. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their reaction to recent developments related to Cognex. This information offers a snapshot of how analysts perceive the current state of the company.</li>
<li>Rating: Analysts assign qualitative assessments to stocks, ranging from 'Outperform' to 'Underperform'. These ratings convey the analysts' expectations for the relative performance of Cognex compared to the broader market.</li>
<li>Price Targets: Analysts predict movements in price targets, offering estimates for Cognex's future value. Examining the current and prior targets offers insights into analysts' evolving expectations.</li>
</ul>
For valuable insights into Cognex's market performance, consider these analyst evaluations alongside crucial financial indicators. Stay well-informed and make prudent decisions using our Ratings Table.
<a href="https://www.benzinga.com/quote/CGNX/analyst-ratings?adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">Stay up to date on Cognex analyst ratings.</a>
<h2>Unveiling the Story Behind Cognex</h2>
Cognex Corp provides machine vision products that help automate manufacturing processes. The firm's products include vision software, vision systems, vision sensors, and ID products. Vision software combines vision tools with a customer's cameras and peripheral equipment and can help with several vision tasks, including part location, identification, measurement, and robotic guidance. Vision systems combine a camera, processor, and vision software into a single package. Vision sensors deliver simple, low-cost solutions for common vision applications, such as checking the size of parts. ID products read codes that have been applied to items during the manufacturing process. Cognex generates the maximum proportion of its sales in the United States and Europe.
<h3>Cognex: Delving into Financials</h3>
Market Capitalization Analysis: The company exhibits a lower market capitalization profile, positioning itself below industry averages. This suggests a smaller scale relative to peers.
Revenue Growth: Cognex's revenue growth over a period of 3M has been noteworthy. As of 31 March, 2025, the company achieved a revenue growth rate of approximately 2.49%. This indicates a substantial increase in the company's top-line earnings. As compared to its peers, the revenue growth lags behind its industry peers. The company achieved a growth rate lower than the average among peers in Information Technology sector.
Net Margin: Cognex's financial strength is reflected in its exceptional net margin, which exceeds industry averages. With a remarkable net margin of 10.93%, the company showcases strong profitability and effective cost management.
Return on Equity (ROE): Cognex's financial strength is reflected in its exceptional ROE, which exceeds industry averages. With a remarkable ROE of 1.59%, the company showcases efficient use of equity capital and strong financial health.
Return on Assets (ROA): Cognex's ROA excels beyond industry benchmarks, reaching 1.2%. This signifies efficient management of assets and strong financial health.
Debt Management: Cognex's debt-to-equity ratio is below industry norms, indicating a sound financial structure with a ratio of 0.05.
<h2>What Are Analyst Ratings?</h2>
Analyst ratings serve as essential indicators of stock performance, provided by experts in banking and financial systems. These specialists diligently analyze company financial statements, participate in conference calls, and engage with insiders to generate quarterly ratings for individual stocks.
Some analysts will also offer forecasts for metrics like growth estimates, earnings, and revenue to provide further guidance on stocks. Investors who use analyst ratings should note that this specialized advice comes from humans and may be subject to error.
Breaking: Wall Street's Next Big Mover
Benzinga's #1 analyst just identified a stock poised for explosive growth. This under-the-radar company could surge 200%+ as major market shifts unfold. <a href="https://www.benzinga.com/premium/ideas/turning-point-trader-checkout-2/?t=Tu1tu3arja3be22tu36&amp;adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantag">Click here for urgent details</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Demystifying Cognex: Insights From 7 Analyst Reviews

Needham analyst James Ricchiuti maintains Cognex (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CGNX#NASDAQ">CGNX</a>) with a Buy and raises the price target from $33 to $36.

Needham Maintains Buy on Cognex, Raises Price Target to $36

IMA E-COMMERCE Enhances Order Fulfillment Efficiency And Sustainability With Cognex's Advanced In-Sight Vision Systems And DataMan Barcode Readers

WIIM

AAOI

AEIS

AEVA

ANET

BELFA

BELFB

CGTL

CIEN

CISO

COHR

COMM

CRSR

CSCO

DELL

DOCN

EBON

ELSE

EPAM

EXTR

FFIV

FLEX

GDYN

GLOB

INFY

IPGP

KEYS

KODK

LFUS

LITE

LOGI

MLGO

NOVT

NTAP

OUST

PSTG

RBBN

SANM

SMCI

SNOW

TAOP

TIXT

TRMB

TSSI

TTMI

TWLO

VNET

VUZI

ZBRA

ZEPP

Shares of companies within the broader tech sector are higher after the US and China agreed to a temporary reduction in most tariffs on each other's goods. A reduction in tariffs could alleviate some supply chain concerns and improve macro sentiment as well as demand visibility.

On May 7, Moschner, President and COO at Cognex (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CGNX#NASDAQ">CGNX</a>), executed a strategic insider move by acquiring stock options for 279,070 shares.
What Happened: Revealed in a Form 4 filing on Wednesday with the <a href="https://www.sec.gov/Archives/edgar/data/0000851205/000205468825000004//Archives/edgar/data/851205/000205468825000004/0002054688-25-000004-index.htm">U.S. Securities and Exchange Commission</a>, Moschner, President and COO at Cognex, strategically acquired stock options for 279,070 shares of CGNX. These options empower Moschner to buy the company's stock at a favorable exercise price of $27.99 per share.
Cognex shares are currently trading down by 0.0%, with a current price of $28.41 as of Thursday morning. This brings the total value of Moschner's 279,070 shares to $117,209.
<h3>Get to Know Cognex Better</h3>
Cognex Corp provides machine vision products that help automate manufacturing processes. The firm's products include vision software, vision systems, vision sensors, and ID products. Vision software combines vision tools with a customer's cameras and peripheral equipment and can help with several vision tasks, including part location, identification, measurement, and robotic guidance. Vision systems combine a camera, processor, and vision software into a single package. Vision sensors deliver simple, low-cost solutions for common vision applications, such as checking the size of parts. ID products read codes that have been applied to items during the manufacturing process. Cognex generates the maximum proportion of its sales in the United States and Europe.
<h3>Breaking Down Cognex's Financial Performance</h3>
Revenue Growth: Cognex displayed positive results in 3 months. As of 31 March, 2025, the company achieved a solid revenue growth rate of approximately 2.49%. This indicates a notable increase in the company's top-line earnings. As compared to competitors, the company surpassed expectations with a growth rate higher than the average among peers in the Information Technology sector.
Profitability Metrics: Unlocking Value
<ul>
<li>
Gross Margin: With a high gross margin of 66.81%, the company demonstrates effective cost control and strong profitability relative to its peers.
</li>
<li>
Earnings per Share (EPS): Cognex's EPS is below the industry average. The company faced challenges with a current EPS of 0.14. This suggests a potential decline in earnings.
</li>
</ul>
Debt Management: The company maintains a balanced debt approach with a debt-to-equity ratio below industry norms, standing at 0.05.
Valuation Metrics:
<ul>
<li>
Price to Earnings (P/E) Ratio: Cognex's P/E ratio of 41.17 is below the industry average, suggesting the stock may be undervalued.
</li>
<li>
Price to Sales (P/S) Ratio: With a relatively high Price to Sales ratio of 5.31 as compared to the industry average, the stock might be considered overvalued based on sales performance.
</li>
<li>
EV/EBITDA Analysis (Enterprise Value to its Earnings Before Interest, Taxes, Depreciation &amp; Amortization): With an impressive EV/EBITDA ratio of 29.11, Cognex demonstrates exemplary market valuation, surpassing industry averages.
</li>
</ul>
Market Capitalization: Indicating a reduced size compared to industry averages, the company's market capitalization poses unique challenges.
<a href="https://www.schwab.com/brokerage?aff=XEC">Now trade stocks online commission free with Charles Schwab, a trusted and complete investment firm.</a>
<h3>Navigating the Impact of Insider Transactions on Investments</h3>
While insider transactions provide valuable information, they should be part of a broader analysis in making investment decisions.
Exploring the legal landscape, an "insider" is defined as any officer, director, or beneficial owner holding more than ten percent of a company's equity securities, as stipulated by Section 12 of the Securities Exchange Act of 1934. This encompasses executives in the c-suite and major hedge funds. These insiders are required to report their transactions through a Form 4 filing, which must be submitted within two business days of the transaction.
Highlighted by a company insider's new purchase, there's a positive anticipation for the stock to rise.
But, insider sells may not necessarily indicate a bearish view and can be motivated by various factors.
<h3>Essential Transaction Codes Unveiled</h3>
Taking a closer look at transactions, <a href="https://www.benzinga.com/money/investing-tools">investors</a> often prioritize those unfolding in the open market, meticulously cataloged in Table I of the Form 4 filing. A P in Box 3 denotes a purchase, while S signifies a sale. Transaction code C denotes the conversion of an option, and transaction code A signifies a grant, award, or other acquisition of securities from the company.
<a href="https://www.benzinga.com/sec/insider-trades/search/index?company_cik=0000851205">Check Out The Full List Of Cognex's Insider Trades.</a>
Insider Buying Alert: Profit from C-Suite Moves
Benzinga Edge reveals every insider trade in real-time. Don't miss the next big stock move driven by insider confidence. Unlock this ultimate sentiment indicator now. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=Be8be9arja3be22in8&amp;adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">Click here for access</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Insider Trades

Matthew Moschner Seizes Opportunity: Acquires $117K Worth Of Cognex Stock Options

Goldman Sachs analyst Joe Ritchie maintains Cognex (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CGNX#NASDAQ">CGNX</a>) with a Sell and lowers the price target from $33 to $29.

Goldman Sachs Maintains Sell on Cognex, Lowers Price Target to $29

DA Davidson analyst Matthew Summerville maintains Cognex (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CGNX#NASDAQ">CGNX</a>) with a Neutral and lowers the price target from $35 to $32.

DA Davidson Maintains Neutral on Cognex, Lowers Price Target to $32

UBS analyst Damian Karas maintains Cognex (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CGNX#NASDAQ">CGNX</a>) with a Buy and lowers the price target from $56 to $53.

UBS Maintains Buy on Cognex, Lowers Price Target to $53

Cognex (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CGNX#NASDAQ">CGNX</a>) has been analyzed by 9 analysts in the last three months, revealing a diverse range of perspectives from bullish to bearish.
The following table encapsulates their recent ratings, offering a glimpse into the evolving sentiments over the past 30 days and comparing them to the preceding months.
<table>
<thead>
<tr>
<th></th>
<th align="right">Bullish</th>
<th align="right">Somewhat Bullish</th>
<th align="right">Indifferent</th>
<th align="right">Somewhat Bearish</th>
<th align="right">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td align="right">3</td>
<td align="right">1</td>
<td align="right">4</td>
<td align="right">0</td>
<td align="right">1</td>
</tr>
<tr>
<td>Last 30D</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">2</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td align="right">2</td>
<td align="right">0</td>
<td align="right">2</td>
<td align="right">0</td>
<td align="right">1</td>
</tr>
</tbody>
</table>
Analysts provide deeper insights through their assessments of 12-month price targets, revealing an average target of $38.89, a high estimate of $56.00, and a low estimate of $26.00. A decline of 12.27% from the prior average price target is evident in the current average. 
<img src="https://www.benzinga.com/files/images/story/2025/1746136876_0.png" alt="price target chart" />
<h2>Decoding Analyst Ratings: A Detailed Look</h2>
The analysis of recent analyst actions sheds light on the perception of Cognex by financial experts. The following summary presents key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>James Ricchiuti</td>
<td>Needham</td>
<td>Lowers</td>
<td>Buy</td>
<td>$33.00</td>
<td>$41.00</td>
</tr>
<tr>
<td>Piyush Avasthy</td>
<td>Citigroup</td>
<td>Lowers</td>
<td>Neutral</td>
<td>$26.00</td>
<td>$37.00</td>
</tr>
<tr>
<td>Jamie Cook</td>
<td>Truist Securities</td>
<td>Lowers</td>
<td>Hold</td>
<td>$29.00</td>
<td>$37.00</td>
</tr>
<tr>
<td>Tommy Moll</td>
<td>Stephens &amp; Co.</td>
<td>Maintains</td>
<td>Overweight</td>
<td>$55.00</td>
<td>$55.00</td>
</tr>
<tr>
<td>Joe Ritchie</td>
<td>Goldman Sachs</td>
<td>Lowers</td>
<td>Sell</td>
<td>$35.00</td>
<td>$39.00</td>
</tr>
<tr>
<td>Damian Karas</td>
<td>UBS</td>
<td>Lowers</td>
<td>Buy</td>
<td>$56.00</td>
<td>$58.00</td>
</tr>
<tr>
<td>Richard Eastman</td>
<td>Baird</td>
<td>Lowers</td>
<td>Neutral</td>
<td>$38.00</td>
<td>$42.00</td>
</tr>
<tr>
<td>Jamie Cook</td>
<td>Truist Securities</td>
<td>Lowers</td>
<td>Hold</td>
<td>$37.00</td>
<td>$43.00</td>
</tr>
<tr>
<td>James Ricchiuti</td>
<td>Needham</td>
<td>Lowers</td>
<td>Buy</td>
<td>$41.00</td>
<td>$47.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: In response to dynamic market conditions and company performance, analysts update their recommendations. Whether they 'Maintain', 'Raise', or 'Lower' their stance, it signifies their reaction to recent developments related to Cognex. This insight gives a snapshot of analysts' perspectives on the current state of the company.</li>
<li>Rating: Analysts assign qualitative assessments to stocks, ranging from 'Outperform' to 'Underperform'. These ratings convey the analysts' expectations for the relative performance of Cognex compared to the broader market.</li>
<li>Price Targets: Gaining insights, analysts provide estimates for the future value of Cognex's stock. This comparison reveals trends in analysts' expectations over time.</li>
</ul>
Understanding these analyst evaluations alongside key financial indicators can offer valuable insights into Cognex's market standing. Stay informed and make well-considered decisions with our Ratings Table.
<a href="https://www.benzinga.com/quote/CGNX/analyst-ratings?adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">Stay up to date on Cognex analyst ratings.</a>
<h2>Delving into Cognex's Background</h2>
Cognex Corp provides machine vision products that help automate manufacturing processes. The firm's products include vision software, vision systems, vision sensors, and ID products. Vision software combines vision tools with a customer's cameras and peripheral equipment and can help with several vision tasks, including part location, identification, measurement, and robotic guidance. Vision systems combine a camera, processor, and vision software into a single package. Vision sensors deliver simple, low-cost solutions for common vision applications, such as checking the size of parts. ID products read codes that have been applied to items during the manufacturing process. Cognex generates the maximum proportion of its sales in the United States and Europe.
<h3>Financial Milestones: Cognex's Journey</h3>
Market Capitalization Perspectives: The company's market capitalization falls below industry averages, signaling a relatively smaller size compared to peers. This positioning may be influenced by factors such as perceived growth potential or operational scale.
Revenue Growth: Over the 3M period, Cognex showcased positive performance, achieving a revenue growth rate of 16.79% as of 31 December, 2024. This reflects a substantial increase in the company's top-line earnings. In comparison to its industry peers, the company stands out with a growth rate higher than the average among peers in the Information Technology sector.
Net Margin: Cognex's net margin surpasses industry standards, highlighting the company's exceptional financial performance. With an impressive 12.34% net margin, the company effectively manages costs and achieves strong profitability.
Return on Equity (ROE): Cognex's ROE stands out, surpassing industry averages. With an impressive ROE of 1.84%, the company demonstrates effective use of equity capital and strong financial performance.
Return on Assets (ROA): Cognex's ROA stands out, surpassing industry averages. With an impressive ROA of 1.4%, the company demonstrates effective utilization of assets and strong financial performance.
Debt Management: Cognex's debt-to-equity ratio is below the industry average at 0.05, reflecting a lower dependency on debt financing and a more conservative financial approach.
<h2>How Are Analyst Ratings Determined?</h2>
Benzinga tracks 150 analyst firms and reports on their stock expectations. Analysts typically arrive at their conclusions by predicting how much money a company will make in the future, usually the upcoming five years, and how risky or predictable that company's revenue streams are.
Analysts attend company conference calls and meetings, research company financial statements, and communicate with insiders to publish their ratings on stocks. Analysts typically rate each stock once per quarter or whenever the company has a major update.
Some analysts publish their predictions for metrics such as growth estimates, earnings, and revenue to provide additional guidance with their ratings. When using analyst ratings, it is important to keep in mind that stock and sector analysts are also human and are only offering their opinions to investors.
Which Stocks Are Analysts Recommending Now?
Benzinga Edge gives you instant access to all major analyst upgrades, downgrades, and price targets. Sort by accuracy, upside potential, and more. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=be8be9arja3be22bz21&amp;adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">Click here to stay ahead of the market</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

A Glimpse Into The Expert Outlook On Cognex Through 9 Analysts

Needham analyst James Ricchiuti maintains Cognex (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CGNX#NASDAQ">CGNX</a>) with a Buy and lowers the price target from $41 to $33.

Needham Maintains Buy on Cognex, Lowers Price Target to $33

Earnings

Earnings Beats

Cognex Q1 Adj. EPS $0.16 Beats $0.13 Estimate, Sales $216.04M Beat $212.97M Estimate

Press Releases

Cognex Announces First Quarter 2025 Earnings Release and Conference Call Dates

Cognex Reports First Quarter 2025 Results; Announces CEO Transition

IMA E-COMMERCE Partners with Cognex for Sustainable and Efficient Order Fulfillment

Cognex to Present at the TD Cowen Technology, Media & Telecom Conference

Cognex Appoints Greer Aviv as Head of Investor Relations

Cognex to Host Investor Day on June 10, 2025

Manufacturers and Logistics Providers Embrace AI for Enhanced Barcode Reading Performance

Cognex Introduces OneVision: A Breakthrough Cloud Platform for AI-Powered Machine Vision

Cognex Announces Second Quarter 2025 Earnings Release and Conference Call Dates

Cognex Announces New Leadership Team to Drive Strategic Growth and Innovation

Advanced Energy Industries, Inc. - Common Stock

Advanced Energy Indus

Aeva Technologies

PowerFleet

Arlo Technologies

Badger Meter

Crane NXT

Daktronics

Evolv Technologies Holdings, Inc. - Class A Common Stock

Evolv Technologies

Itron

Keysight Techs

nLight

Mirion Technologies, Inc. Class A Common Stock

Mirion Technologies

Microvision

Novanta

NAPCO Security Technologies, Inc. - Common Stock

NAPCO Security Techs

OSI Systems

Ouster

PAR Technology

Ralliant

Red Cat Holdings

Teledyne Technologies Incorporated Common Stock

Teledyne Technologies

Trimble

Vontier

Zebra Technologies Corporation - Class A Common Stock

Zebra Technologies

Zepp Health Corporation American depositary shares, each representing sixteen Class A ordinary shares

Comments

Cognex

Intérêt court

Cognex (NASDAQ:CGNX) Stock, Rapport sur les intérêts à découvert

Les gens regardent aussi

Notizie

PARTENAIRE / CONTRIBUTEUR

BENZINGA MONDIAL